-LifeViroTreat –A Potential Remedy for covid-19 treatment.
Product Name | LifeViroTreat. |
Therapy Type | Inhalation through nebulizer. |
Indication | Treatment for COVID-19, It can also be explored for other flu, influenza and other virus respiratory disease. |
Drug Classification | New Drug. |
Drug Substance | Non-pharmacopoeia. |
Intellectual Property Status | PCT filing activity for pharmaceutical composition as an inhaler is completed in October 2020 with priority date April 2020. |
Future Strategy | New IP support filing will be explored. |
Status of Drug at CDGI-India | Phase-I trial is permitted and going to start by next week. |
Treatment duration | Nebulise for 15 min every 4 hrs for 3 days. |